1. Home
  2. MGTX vs STAA Comparison

MGTX vs STAA Comparison

Compare MGTX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

BUY

Current Price

$10.89

Market Cap

1.0B

Sector

Health Care

ML Signal

BUY

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

SELL

Current Price

$22.46

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MGTX
STAA
Founded
2015
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
MGTX
STAA
Price
$10.89
$22.46
Analyst Decision
Buy
Hold
Analyst Count
8
12
Target Price
★ $27.75
$27.70
AVG Volume (30 Days)
★ 932.9K
845.1K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.02
N/A
EPS
★ 1.30
0.26
Revenue
$81,391,000.00
★ $239,442,000.00
Revenue This Year
$314.19
$39.61
Revenue Next Year
N/A
$7.86
P/E Ratio
★ $8.40
$86.81
Revenue Growth
★ 144.57
N/A
52 Week Low
$6.62
$15.59
52 Week High
$15.35
$35.87

Technical Indicators

Market Signals
Indicator
MGTX
STAA
Relative Strength Index (RSI) 31.37 50.99
Support Level $8.84 $21.72
Resistance Level $11.85 $24.31
Average True Range (ATR) 0.58 0.90
MACD -0.18 0.26
Stochastic Oscillator 13.29 82.91

Price Performance

Historical Comparison
MGTX
STAA

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Share on Social Networks: